Trial
NCT06786637
Investigating the Protective Impact of LY-2940094 on Stress-induced Depression- and Anxiety-related Phenotypes in Humans
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Mclean Hospital
Collaborators
National Institute of Mental Health (NIMH)
Condition
Depression - Major Depressive Disorder
Intervention
Nociceptin Receptor Antagonist (LY-2940094)
Why stopped
PI transferred to a different research institution and local institution would not allow to continue the study. Transfer of the study to a different study site not possible because of unique requirements of resources (e.g., nociceptin anatagonist)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-25